HB 8092025–2026
bill
2025–2026 Regular Session · House of Representatives bill
HB 809
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for prohibited acts and penalties; and providing for syringe service programs authorized.
In committee Last action March 5, 2025: Referred to Judiciary
Official bill page and text: palegis.us
Sponsors 7
- Prime sponsor
- James Struzzi
- Cosponsors (6)
- Benjamin Sanchez, Dan Frankel, G. Roni Green, Lindsay Powell, Steven Malagari, Tarik Khan
Status
In committee as of March 5, 2025. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.
Roll-call votes 0
No roll-call votes recorded for this measure.
Timeline 1
| Date | Chamber | Action |
|---|---|---|
| March 5, 2025 | House | Referred to Judiciary |
Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.